Cogent Biosciences (COGT) Share-based Compensation (2017 - 2021)
Historic Share-based Compensation for Cogent Biosciences (COGT) over the last 5 years, with Q4 2021 value amounting to $3.9 million.
- Cogent Biosciences' Share-based Compensation rose 34480.37% to $3.9 million in Q4 2021 from the same period last year, while for Dec 2021 it was $11.7 million, marking a year-over-year increase of 9421.64%. This contributed to the annual value of $39.7 million for FY2024, which is 2978.02% up from last year.
- Per Cogent Biosciences' latest filing, its Share-based Compensation stood at $3.9 million for Q4 2021, which was up 34480.37% from $3.5 million recorded in Q3 2021.
- Cogent Biosciences' Share-based Compensation's 5-year high stood at $3.9 million during Q4 2021, with a 5-year trough of $282000.0 in Q2 2017.
- Over the past 5 years, Cogent Biosciences' median Share-based Compensation value was $853500.0 (recorded in 2018), while the average stood at $1.3 million.
- Its Share-based Compensation has fluctuated over the past 5 years, first tumbled by 837.21% in 2019, then skyrocketed by 34568.53% in 2020.
- Over the past 5 years, Cogent Biosciences' Share-based Compensation (Quarter) stood at $460000.0 in 2017, then skyrocketed by 96.09% to $902000.0 in 2018, then dropped by 6.65% to $842000.0 in 2019, then increased by 2.85% to $866000.0 in 2020, then surged by 344.8% to $3.9 million in 2021.
- Its last three reported values are $3.9 million in Q4 2021, $3.5 million for Q3 2021, and $2.6 million during Q2 2021.